No Detail Found!

Comparison of urinary periostin, urinary alpha-1-microglobulin and urinary albumin to creatinine ratio in patients of Type 2 Diabetes Mellitus

Author(s)
Muhammad Umer Department of Chemical Pathology, Sheikh Zayed Medical College/Hospital, Rahim Yar Khan, Pakistan
Rushna Liaqat Department of Chemical Pathology, Sheikh Zayed Medical College/Hospital, Rahim Yar Khan, Pakistan
Muhammad Shahbaz Hussain Department of Chemical Pathology, Sheikh Zayed Medical College/Hospital, Rahim Yar Khan, Pakistan
Sumbla Ghaznavi University of Health Sciences, Lahore, Pakistan
Nadia Rasheed University of Health Sciences, Lahore, Pakistan
Maham Shakoor University of Health Sciences, Lahore, Pakistan
Abstract
Objective: To determine and compare the levels of urinary periostin, urinary alpha-1-microglobulin and urinary albumin to creatinine ratio in patients of type 2 diabetes mellitus whose diabetic duration is less than five years. Methodology: A total of 84 type 2 diabetic individuals were included in this cross-sectional comparative study. The patients were divided into three groups. Group 1 comprised of 28 patients with 2 to 3 years duration of diabetes. Group 2 comprised of 28 patients with 3 to 4 years duration of diabetes. Group 3 comprised of 28 patients with 4 to 5 years duration of diabetes. Spot urine specimens were collected and examined for urinary creatinine, microalbumin, alpha-1microglobulin and periostin. Urinary albumin (mg/dl) was divided by creatinine (g/dl) to calculate albumin to creatinine ratio. Results: Out of 84 patients, 48 were males, and 36 females. Mean of urinary albumin to creatinine ratio was 9.21 ± 1.8 in group 1, 13.7 ± 3.2 in group 2 and 22.95 ± 5.30 in group 3. Mean of urinary alpha-1-microglobulin was 20.89 ± 3.1 in group 1, 30.9 ± 3.4 in group 2 and 43.3 ± 4.4 in group 3. Mean of urinary peri-ostin was 0.7 ± 0.13 in group 1, 1.34 ± 0.14 in group 2 and 1.92 ± 0.13 in group 3. One-way ANOVA compari-son showed that Group 3 had highest levels of these urinary parameters. These results showed strong asso-ciation of all these three urinary parameters with dis-ease duration. Conclusion: This study concludes that urinary alpha-1-microglobulin and urinary periostin are good mar-kers for early diagnosis and progression of diabetic nephropathy.
Publication Details
Page(s) 565-568
DOI DOI not available
Published Journal: Rawal Medical Journal, Volume: 50, Issue: 3, Year: 2025

Request the full text from PASTIC

Keywords
diabetic nephropathy, Diabetes mellitus, Diabetes mellitus, Periostin, alpha-1-microglobulin, albumin to creatinine ratio.
References
Rajlic S,Treede H,Münzel T,Daiber A,Duerr GD .2023 .Early detection is the best prevention-Characterization of oxidative stress in diabetes mellitus and its consequences on the cardiovascular system. Cell, 12 : 583-8.
Jan A,Zakiullah A,Ali S,Muhammad B,Arshad A,Shah Y .2023 .Decoding type 2 diabetes mellitus genetic risk variants in Pakistani Pashtun ethnic population using the nascent whole exome sequencing and Mass ARRAY genotyping: A case-control association study. Plos one, 18 : e0281070.
Samsu N. .2021 .Diabetic nephropathy: challenges in pathogenesis, diagnosis, and treatment. Biomed Res Int, : 1497449.
Naseer S,Malkera A,Khan N,Siddiqui AH,Khan SA,Ali S .2022 .Prevalence of diabetic complications in urban and rural population of Punjab. Pak J Med Health Sci, 16 : 69-72.
.2021 .Microvascular complications and foot care: standards of medical care in diabetes-2021. Diabetes Care, 44 : 151-67.
Hussain S,Jamali MC,Habib A,Hussain MS,Akhtar M,Najmi AK .2021 .Diabetic kidney disease: An overview of prevalence, risk factors, and biomarkers. Clin Epidemiol Glob Health, 9 : 2-6.
Swaminathan SM,Rao IR,Shenoy SV,Prabhu AR,Mohan PB,Rangaswamy D .2023 .Novel biomarkers for prognosticating diabetic kidney disease progression. Int Urol Nephrol, 55 : 913-28.
Canki E,Kho E,Hoenderop JG .2024 .Urinary biomarkers in kidney disease. Clin Chim Acta, 555 : 117798.
Amatruda JG,Estrella MM,Garg AX,Thiessen-Philbrook H,McArthur E,Coca SG .2021 .Urine alpha-1-microglobulin levels and acute kidney injury, mortality, and cardiovascular events following cardiac surgery. Am J Nephrol, 52 : 673-83.
Abbad L,Prakoura N,Michon A,Chalghoumi R,Reichelt-Wurm S,Banas MC .2022 .Role of periostin and nuclear factor-κb interplay in the development of diabetic nephropathy. Cells, 11 : 2212-5.
Bae J,Lee B-W. .2023 .Significance of Diabetic Kidney Disease Biomarkers in Predicting Metabolic-Associated Fatty Liver Disease. Biomedicines, 11 : 1928-32.
Sana MA,Chaudhry M,Malik A,Iqbal N,Zakiuddin A,Abdullah M. .2020 .Prevalence of microalbuminuria in type 2 diabetes mellitus. Cureus, 12 : e12318.
Abdel Ghafar MT,Shalaby KH,Okda HI,Abo El-Gheit RE,Soliman NA,Keshk WA .2020 .Assessment of two novel renal tubular proteins in type 2 diabetic patients with nephropathy. J Invest Med, 68 : 748-55.
Mahfouz MH,Shoman MS,Hassan ME .2020 .Assessment of urinary type IV collagen, alpha-1 microglobulin, and transferrin in type 2 diabetes mellitus with nephropathy. J Med Scientific Res, 3 : 18-22.
0

Citations

0

Downloads

106

Views